Related Experiment Video
Updated: Dec 15, 2025

Controllable Ion Channel Expression through Inducible Transient Transfection
Published on: February 17, 2017
Characterisation of d-Conotoxin TxVIA as a Mammalian T-Type Calcium Channel Modulator
Dan Wang1, S W A Himaya1, Jean Giacomotto2,3
1Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
The conotoxin TxVIA, from cone snails, does not affect mammalian sodium channels but inhibits T-type calcium channels, specifically CaV3.2. This reveals new potential targets for conotoxin research.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- d-conotoxin TxVIA, isolated from *Conus textile*, modulates voltage-gated sodium (NaV) channel inactivation in molluscan neurons.
- Mammalian NaV channel targets for TxVIA are currently unknown.
Purpose of the Study:
- To investigate the activity of TxVIA on mammalian ion channels, particularly T-type calcium channels (CaV3.x).
- To identify potential mammalian targets and binding sites for TxVIA.
Main Methods:
- Electrophysiological characterization of TxVIA on CaV3.1, CaV3.2, and CaV3.3 channels.
- Assessment of TxVIA activity on mammalian NaV1.2 and NaV1.7 channels.
- Fish bioassays using zebrafish to evaluate behavioral effects.
- Analysis of TxVIA binding sites on NaV1.7 and CaV3.1 channels.
Main Results:
- TxVIA showed no activity on mammalian NaV1.2 and NaV1.7 channels at concentrations up to 10 µM.
- TxVIA preferentially inhibited CaV3.2 currents (IC50 = 0.24 mM) and enhanced CaV3.1 currents at higher concentrations.
- TxVIA exhibited minimal behavioral effects in zebrafish bioassays.
- Common epitopes were identified at the binding sites of TxVIA on NaV1.7 and CaV3.1 channels.
Conclusions:
- TxVIA does not target mammalian NaV channels but acts on T-type calcium channels, with a preference for CaV3.2 inhibition.
- The study identifies CaV3.2 and CaV3.1 as potential mammalian targets for TxVIA.
- The presence of a common binding epitope suggests evolutionary relationships between NaV and CaV channel binding sites for TxVIA.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antihypertensive Drugs: Action of Calcium Channel Blockers
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

